Microcap Ledger biote Corp. $BTMD
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Market
- Sector
- Medicinal Chemicals & Botanical Products
- Headquarters
- Irving, TX
- Fiscal year end
- December 31
What the company doesAI summary of filing
Biote Corp. operates a practice-building platform in the hormone optimization space, providing education, training, certification, software tools, and practice support to healthcare practitioners who treat hormone imbalance in patients. The company generates revenue primarily through service fees from Biote-certified practitioners and clinics for access to the Biote Method platform, as well as from sales of Biote-branded dietary supplements, which represented approximately 22% of revenue in 2025. As of December 31, 2025, Biote had contracted with over 9,200 practitioners in more than 5,300 clinics nationwide. The company is revenue-generating, with annual revenues of $192.2 million in 2025 and net income of $31.6 million. [10-K 2026-03-13]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $89.17M | −$4.29M | $2.73M | $11.17M | [10-Q 2026-08-07] |
| FY ended Dec 2025 | $192.22M | $27.05M | $35.19M | $24.12M | [10-K 2026-03-13] |
| FY ended Dec 2024 | $197.19M | $3.16M | $45.24M | $39.34M | [10-K 2026-03-13] |
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-11 | Beer Marc D | buy | 16,000 | $1.55 | [4 2026-08-12] |
| 2026-08-10 | Beer Marc D | buy | 115,950 | $1.53 | [4 2026-08-12] |
| 2026-05-12 | Morris Debra L | exercise | 21,407 | — | [4 2026-05-13] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-18 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-09-01 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-28 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-08-07 | 10-Q | Quarterly report |
| 2026-08-05 | 8-K | Results of operations |
| 2026-07-27 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-06-17 | 8-K | Director or officer change |
| 2026-06-02 | 8-K | Director or officer change; Regulation FD disclosure |
| 2026-05-18 | 8-K | Shareholder vote results |
| 2026-05-13 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-11 | 10-Q | Quarterly report |
| 2026-05-06 | 8-K | Results of operations |
Alerts for $BTMD
Email me when biote Corp. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.